Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1464592

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1464592

Electrophysiology Ablation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

PUBLISHED:
PAGES: 145 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4000
PDF (Site License)
USD 8000
PDF (Global License)
USD 12000

Add to Cart

GlobalData's Medical Devices sector report, "Electrophysiology Ablation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Electrophysiology Ablation Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

An electrophysiology ablation catheter contains an electrode on one end which emits RF waves to destroy a small area of heart tissue in the abnormal conduction pathway, blocking further channeling of the impulses causing the heart's abnormal rhythm.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Electrophysiology Ablation Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Electrophysiology Ablation Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Electrophysiology Ablation Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Product Code: GDME1725EPD

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Electrophysiology Ablation Catheters Overview

3 Products under Development

  • 3.1 Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development
  • 3.2 Electrophysiology Ablation Catheters - Pipeline Products by Segment
  • 3.3 Electrophysiology Ablation Catheters - Pipeline Products by Territory
  • 3.4 Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path
  • 3.5 Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date
  • 3.6 Electrophysiology Ablation Catheters - Ongoing Clinical Trials

4 Electrophysiology Ablation Catheters - Pipeline Products under Development by Companies

  • 4.1 Electrophysiology Ablation Catheters Companies - Pipeline Products by Stage of Development
  • 4.2 Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development

5 Electrophysiology Ablation Catheters Companies and Product Overview

  • 5.1 Ablacon Inc Company Overview
    • 5.1.1 Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Acotec Scientific Co Ltd Company Overview
    • 5.2.1 Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Adagio Medical Inc. Company Overview
    • 5.3.1 Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Apama Medical Inc Company Overview
    • 5.4.1 Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 APT Medical Inc Company Overview
    • 5.5.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Biosense Webster Inc Company Overview
    • 5.6.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 BioTex Inc Company Overview
    • 5.7.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Boston Scientific Corp Company Overview
    • 5.8.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 CardioFocus Inc Company Overview
    • 5.9.1 CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 CardioNova Ltd Company Overview
    • 5.10.1 CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 CathEffects LLC Company Overview
    • 5.11.1 CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 CathRx Ltd Company Overview
    • 5.12.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Cibiem, Inc. Company Overview
    • 5.13.1 Cibiem, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Columbia University Company Overview
    • 5.14.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Cordis US Corp Company Overview
    • 5.15.1 Cordis US Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 CoreMap Inc Company Overview
    • 5.16.1 CoreMap Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 Coridea, LLC Company Overview
    • 5.17.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 CryoTherapeutics SA Company Overview
    • 5.18.1 CryoTherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 Epicardial Technologies Inc (Inactive) Company Overview
    • 5.19.1 Epicardial Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 Ethicon US LLC Company Overview
    • 5.20.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 Farapulse Inc Company Overview
    • 5.21.1 Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 FocusStart LLC Company Overview
    • 5.22.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 Galvanize Therapeutics Inc Company Overview
    • 5.23.1 Galvanize Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 Hansen Medical Inc (Inactive) Company Overview
    • 5.24.1 Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 Hyblate Medical Company Overview
    • 5.25.1 Hyblate Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26 Imricor Medical Systems Inc Company Overview
    • 5.26.1 Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27 Interventional Imaging, Inc. Company Overview
    • 5.27.1 Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28 Iowa Approach Inc. Company Overview
    • 5.28.1 Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29 Japan Lifeline Co Ltd Company Overview
    • 5.29.1 Japan Lifeline Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30 Maestro Heart SA Company Overview
    • 5.30.1 Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31 Medlumics SL Company Overview
    • 5.31.1 Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32 MedWaves Inc Company Overview
    • 5.32.1 MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33 MicroPort Scientific Corp Company Overview
    • 5.33.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34 Northwestern University Company Overview
    • 5.34.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35 Novasentis Inc Company Overview
    • 5.35.1 Novasentis Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36 OrbusNeich Company Overview
    • 5.36.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37 SCR, Inc. Company Overview
    • 5.37.1 SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38 Seattle Children's Hospital Company Overview
    • 5.38.1 Seattle Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39 Shanghai HeartCare Medical Technology Co Ltd Company Overview
    • 5.39.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40 Shanghai MicroPort EP MedTech Co Ltd Company Overview
    • 5.40.1 Shanghai MicroPort EP MedTech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41 St. Jude Medical LLC Company Overview
    • 5.41.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42 Stereotaxis Inc Company Overview
    • 5.42.1 Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43 University of Arkansas at Little Rock Company Overview
    • 5.43.1 University of Arkansas at Little Rock Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44 University of Michigan Company Overview
    • 5.44.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45 University of Rochester Company Overview
    • 5.45.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
  • 5.46 University of Texas Medical Branch at Galveston Company Overview
    • 5.46.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
  • 5.47 Vanderbilt University Company Overview
    • 5.47.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.48 Vimecon GmbH Company Overview
    • 5.48.1 Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.49 Vivonics Inc Company Overview
    • 5.49.1 Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.50 Voyage Medical (Inactive) Company Overview
    • 5.50.1 Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

6 Electrophysiology Ablation Catheters- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
Product Code: GDME1725EPD

List of Tables

  • Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development
  • Electrophysiology Ablation Catheters - Pipeline Products by Segment
  • Electrophysiology Ablation Catheters - Pipeline Products by Territory
  • Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path
  • Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date
  • Electrophysiology Ablation Catheters - Ongoing Clinical Trials
  • Electrophysiology Ablation Catheters Companies - Pipeline Products by Stage of Development
  • Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development
  • Glossary

List of Figures

  • Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development
  • Electrophysiology Ablation Catheters - Pipeline Products by Segment
  • Electrophysiology Ablation Catheters - Pipeline Products by Territory
  • Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path
  • Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date
  • Electrophysiology Ablation Catheters - Ongoing Clinical Trials
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!